Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited said it has received approval from the US health regulator to market a generic medication
April 25, 2023: In a significant development, Zydus Lifesciences has received the approval of the United States Food and Drug Administration (USFDA) for its generic medication.
The medication is expected to help in the treatment of a wide range of medical conditions and will be available in the market soon.
Zydus Lifesciences, the subsidiary of the leading pharmaceutical company Zydus Cadila, has been granted approval for its generic medication by the USFDA after successfully passing all the required tests and meeting the regulatory standards.
The medication will be available in various strengths and dosage forms, providing greater flexibility in the treatment of different medical conditions.
This approval from the USFDA is a significant achievement for Zydus Lifesciences and a testament to the company’s commitment to providing high-quality healthcare solutions to people around the world.
The generic medication is expected to provide a more affordable alternative to the brand-name medication, thereby increasing access to healthcare for patients.
Speaking about the approval, Mr. Pankaj R. Patel, Chairman, and Managing Director, Zydus Cadila, said, “We are delighted to receive the USFDA approval for our generic medication.
This approval is a testament to our commitment to providing affordable and high-quality healthcare solutions to people around the world.
We remain committed to enhancing our product portfolio and making a difference in the lives of people through our innovative products.”
Zydus Lifesciences has a strong portfolio of generic medications and has a significant presence in the global pharmaceutical market.
With the approval of this medication, the company is expected to further strengthen its position and expand its reach in the US market.
The medication will be manufactured at the company’s state-of-the-art manufacturing facility in India and will be available in the US market soon.
| Are you an
Entrepreneur or Startup? Do you have a Success Story to Share? SugerMint would like to share your success story. We cover entrepreneur Stories, Startup News, Women entrepreneur stories, and Startup stories
|
Read more Business Stories at SugerMint. Follow us on Twitter, Instagram, Facebook, LinkedIn for latest company news and corporate updates.